Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nerve growth factor (NGF) is a neurotrophin protein that plays a critical role in the growth, maintenance, and survival of sympathetic and sensory neurons. In adults, NGF regulates neuronal regeneration after injury and modulates pain perception by binding primarily to the tropomyosin receptor kinase A (TrkA) with high affinity and to p75 with low affinity. Activation of these receptors initiates intracellular signaling pathways involved in cell survival, proliferation, or apoptosis. NGF is elevated in various chronic pain conditions such as osteoarthritis, interstitial cystitis, arthritis, pancreatitis, cancer pain, and diabetic neuropathy. Recombinant or exogenous NGF has been investigated for its potential therapeutic effects in neurological disorders including Alzheimer's disease and traumatic brain injury[2][3][4][6]. However, most clinical development has focused on inhibitors of NGF for chronic pain management.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Nerve growth factor.